Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,157 public trials 307 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

NCT00086034

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: San Diego, California, United States

Stanford, California, United States

Miami, Florida, United States

Chicago, Illinois, United States

View Trial Details

Completed

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

NCT00299780

Conditions: Acute Myelogenous Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dose Reduction in Thoracic CT

NCT00188461

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Toronto General Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

NCT00037791

Conditions: Blood Platelet Disorders, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Pfizer Investigational Site Berkeley, California, United States

Pfizer Investigational Site La Jolla, California, United States

Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View Trial Details

Completed

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma

NCT00138086

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium

Hôpital Henri Mondor Créteil, France

Hématologie CHU de Lille Lille, France

Institut Curie Paris, France

View Trial Details

Completed

A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors

NCT00001579

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00054808

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Genta Berkeley Heights, New Jersey, United States

View Trial Details

Completed

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

NCT00035022

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Ultrasound Biomicroscopy - Apoptosis

NCT00188370

Conditions: Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Subcutaneous Amifostine Safety Study

NCT00158041

Conditions: Cardiovascular Diseases, Digestive System Diseases, Exanthema, +30 more
Locations: Mt. Sinai Medical Center Miami Beach, Florida, United States

View Trial Details